These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21289211)

  • 21. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
    [No Abstract]   [Full Text] [Related]  

  • 22. The target hemoglobin in non-dialysis CKD: still a matter for debate?
    Kuriyama S
    Clin Exp Nephrol; 2010 Jun; 14(3):298-9. PubMed ID: 20300796
    [No Abstract]   [Full Text] [Related]  

  • 23. Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial.
    Macdougall IC; Temple RM; Kwan JT
    Nephrol Dial Transplant; 2007 Mar; 22(3):784-93. PubMed ID: 16968726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correction of anemia in renal insufficiency: what target?].
    Drüeke TB
    Nephrol Ther; 2008 Oct; 4 Spec No 2():1-8. PubMed ID: 19000892
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyporesponse to Epoetin alfa: patients at risk. Case study of the anemic patient.
    Deziel SM
    Nephrol Nurs J; 2002 Feb; 29(1):60-3. PubMed ID: 11887489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment anaemia of chronic kidney disease in predialysis patients (stage 1-4)].
    Lovcić V; Vujić J; Ivanac Janković R; Basić-Jukić N; Barisić I; Lovcić P; Dzapo M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():11-6. PubMed ID: 20232547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life and anemia: the nephrology experience.
    Macdougall IC
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):39-42. PubMed ID: 9671329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in patients on dialysis: benefits of maintaining a hemoglobin of 11 to 12 g/dL.
    Gregory N
    Nephrol Nurs J; 2005; 32(3):307-10. PubMed ID: 16035472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.
    KDOQI
    Am J Kidney Dis; 2007 Sep; 50(3):471-530. PubMed ID: 17720528
    [No Abstract]   [Full Text] [Related]  

  • 30. Quality of life assessment in a recent haemoglobin trial in CKD (CHOIR).
    Kutner N
    Nephrol Dial Transplant; 2007 Jul; 22(7):2099. PubMed ID: 17395656
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of erythropoietins in patients with renal transplants.
    Treleaven DJ; Clase CM
    BMJ; 2009 Oct; 339():b3825. PubMed ID: 19854838
    [No Abstract]   [Full Text] [Related]  

  • 32. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causes and consequences of inflammation on anemia management in hemodialysis patients.
    Chawla LS; Krishnan M
    Hemodial Int; 2009 Apr; 13(2):222-34. PubMed ID: 19432697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.
    Breiterman-White R
    Nephrol Nurs J; 2002 Oct; 29(5):469-72. PubMed ID: 12434453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemoglobin variability in patients with chronic renal insuffiency].
    Deray G
    Nephrol Ther; 2008 Dec; 4(7):549-52. PubMed ID: 19004677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anemia management protocols: providing consistent hemoglobin outcomes.
    Michael M
    Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
    Williams JS; Stein JH; Ferris TF
    Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
    [No Abstract]   [Full Text] [Related]  

  • 39. European best practice guidelines 1-4: evaluating anaemia and initiating treatment.
    Valderrábano F; Hörl WH; Jacobs C; Macdougall IC; Parrondo I; Cremers S; Abraham IL
    Nephrol Dial Transplant; 2000; 15 Suppl 4():8-14. PubMed ID: 11052144
    [No Abstract]   [Full Text] [Related]  

  • 40. European best practice guidelines 9-13: anaemia management.
    Jacobs C; Hörl WH; Macdougall IC; Valderrábano F; Parrondo I; Abraham IL; Segner A
    Nephrol Dial Transplant; 2000; 15 Suppl 4():33-42. PubMed ID: 11052147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.